Skip to main content
. 2021 Jun 22;11:13025. doi: 10.1038/s41598-021-92508-1

Table 3.

Association between lipoprotein subfractions concentration and high-MBD cases, compared to low-MBD BC cases, in the 87 sets (EPIC Florence, low- vs high-MBD BC case–case study).

Conditional logistic regressiona Adjusted conditional logistic regression b
Odds ratio (95%CI) for 1 SD p value Odds ratio (95%CI) for 1 SD p value p value FDR c
LipoproteinMainFractionsTrigVLDL 0.65 (0.46–0.91) 0.014 1.43 (0.79–2.61) 0.238 NS
LipoproteinMainFractionsCholVLDL 0.68 (0.49–0.95) 0.025 1.57 (0.86–2.85) 0.141 NS
LipoprMainFractionsFreeCholVLDL 0.67 (0.47–0.93) 0.018 1.47 (0.82–2.64) 0.201 NS
LipoproteinMainFractionsPhosVLDL 0.66 (0.47–0.93) 0.018 1.50 (0.82–2.73) 0.186 NS
LipoproteinMainFractionsApoBVLDL 0.56 (0.33–0.96) 0.035 1.47 (0.85–2.53) 0.171 NS
SubfractionsTriglyceridesVLDL1 0.50 (0.31–0.80) 0.004 1.27 (0.63–2.56) 0.511 NS
SubfractionsTriglyceridesVLDL5 0.65 (0.46–0.92) 0.015 0.88 (0.53–1.47) 0.624 NS
SubfractionsCholesterolVLDL1 0.60 (0.42–0.86) 0.005 1.38 (0.75–2.52) 0.304 NS
SubfractionsCholesterolVLDL5 0.57 (0.33–0.98) 0.042 1.05 (0.51–2.16) 0.893 NS
SubfractionsFreeCholesterolVLDL2 1.04 (0.77–1.41) 0.790 2.05 (1.24–3.39) 0.005 NS
SubfractionsFreeCholesterolVLDL3 1.20 (0.87–1.66) 0.256 1.92 (1.08–3.41) 0.026 NS
SubfractionsFreeCholesterolVLDL4 1.04 (0.77–1.40) 0.818 1.72 (1.04–2.83) 0.035 NS
SubfractionsPhospholipidsVLDL1 0.55 (0.36–0.85) 0.006 1.49 (0.75–2.98) 0.259 NS
SubfractionsPhospholipidsVLDL5 0.51 (0.28–0.90) 0.021 1.02 (0.48–2.21) 0.951 NS

aOdds ratios per standard deviation (SD) increase in metabolite concentration conditioned on age at cohort entry (± 5 years), type of mammographic examination (analogical/digital; negative/diagnostic) and year of mammographic examination (before/after 2000). Single lipoprotein subfractions separately added to the regression model.

bOdds ratios per standard deviation (SD) increase in metabolite concentration conditioned on age at cohort entry (± 5 years), type of mammographic examination (analogical/digital; negative/diagnostic) and year of mammographic examination (before/after 2000) and adjusted for age at diagnosis, number of full-term pregnancies, breastfeeding (yes/no), menopausal status, ER status, body mass index. Single lipoprotein subfractions separately added to the regression model.

cp values adjusted for false discovery rate (FDR) at α = 0.05 with Benjamini–Hochberg correction.